Search Results - guohong+hu

1 Results

Sort By:

Metadherin: Therapeutic Target for Treating Primary and Metastatic Cancer and Combating Chemoresistance

Princeton Docket # 07-2399 Researchers in the Molecular Biology Department at Princeton University have identified a recurrent 8q22 genomic gain in poor-prognosis human breast cancers, which harbors the metastasis gene Metadherin (MTDH). Genomic gain of 8q22 elevates expression of MTDH, which is overexpressed in more than 40% of breast cancers...

Published: 9/6/2022 | Inventor(s): Yibin Kang, Guohong Hu

Keywords(s): Biotechnology/Pharmaceuticals, cancer/oncology, drug target, life science venture/early

Category(s): Medical Devices/Diagnostics, Biotechnology/Pharmaceuticals